These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17697748)

  • 21. [Bisphosphonates in oncology].
    Soltau J; Medinger M; Unger C; Drevs J
    Med Monatsschr Pharm; 2003 Dec; 26(12):411-7. PubMed ID: 14699777
    [No Abstract]   [Full Text] [Related]  

  • 22. The critical role of bisphosphonates to target bone cancer metastasis: an overview.
    Singh T; Kaur V; Kumar M; Kaur P; Murthy RS; Rawal RK
    J Drug Target; 2015 Jan; 23(1):1-15. PubMed ID: 25203856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates and cancer.
    Milner RJ; Farese J; Henry CJ; Selting K; Fan TM; de Lorimier LP
    J Vet Intern Med; 2004; 18(5):597-604. PubMed ID: 15515572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The crossover of bisphosphonates to cancer therapy.
    Sun M; Iqbal J; Singh S; Sun L; Zaidi M
    Ann N Y Acad Sci; 2010 Nov; 1211():107-12. PubMed ID: 21062299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoledronic acid: past, present and future roles in cancer treatment.
    Saad F
    Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonate anticancer activity in multiple myeloma.
    Terpos E
    Anticancer Agents Med Chem; 2012 Feb; 12(2):123-8. PubMed ID: 21864228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer activity of bisphosphonates in breast cancer.
    Gnant M
    Anticancer Agents Med Chem; 2012 Feb; 12(2):114-22. PubMed ID: 21864231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumour effects of bisphosphonates: first evidence and possible mechanisms.
    Diel IJ
    Drugs; 2000 Mar; 59(3):391-9. PubMed ID: 10776826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonates and Cancer: A Relationship Beyond the Antiresorptive Effects.
    Teixeira S; Branco L; Fernandes MH; Costa-Rodrigues J
    Mini Rev Med Chem; 2019; 19(12):988-998. PubMed ID: 31020940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
    Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
    Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G; Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumorigenic effects of cannabinoids beyond apoptosis.
    Freimuth N; Ramer R; Hinz B
    J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates as treatment of bone metastases.
    Holen I; Coleman RE
    Curr Pharm Des; 2010; 16(11):1262-71. PubMed ID: 20166976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
    Clézardin P
    Bone; 2011 Jan; 48(1):71-9. PubMed ID: 20655399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of bisphosphonates on bone metastasis of hormone-refractory prostate cancer].
    Tanaka T; Kawashima H; Kuratsukuri K; Sugimura K; Nakatani T
    Hinyokika Kiyo; 2006 Jun; 52(6):491-4. PubMed ID: 16848364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role of bisphosphonates in prostate cancer.
    Oades GM; Coxon J; Colston KW
    Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates: new antiangiogenic molecules in cancer treatment?
    Vincenzi B; Santini D; Rocci L; Tonini G
    Ann Oncol; 2003 May; 14(5):806-7. PubMed ID: 12702541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.